Established in 1942, the NIAID Laboratory of Infectious Diseases (LID) has a long history of discovering new agents of viral diseases and developing innovative vaccines and treatments such as FluMist, a nasal spray influenza vaccine; Synagis, a preventative treatment for respiratory syncytial virus; and Havrix, a hepatitis A vaccine licensed by GlaxoSmithKline.
Featured Trials
Screening Healthy Volunteers for Influenza Challenge Studies
If you are healthy, have some time, and have an interest in helping researchers make discoveries about influenza (the flu), we need you for a screening study. The screening is used to determine eligibility for future studies that will help researchers learn more about the development and course of the flu virus.
Viral Infections in Non-Immunocompromised Patients
This study seeks patients who are thought to have normal immune systems but who have been diagnosed with a viral infection that is unusually severe, prolonged, or persistent. This study will evaluate the participants' immune systems to determine why the infection developed.
Clinical Trials Sponsored by the Laboratory of Infectious Diseases Clinic
The clinical trials and studies conducted by the Laboratory of Infectious Diseases Clinical Research Program change frequently, but you can see a list of all current clinical trials and studies being conducted by the Laboratory of Infectious Diseases Clinic on our Find a Clinical Trial page.
The LID Clinical Studies Unit (LID CSU) seeks to perform translational research studies to answer fundamental questions regarding human influenza and other emerging viral infections to inform and impact future vaccine and therapeutic design, while also making an effort to assist in evaluation of novel products that may impact human health.
In recent years, the LID CSU has initiated efforts to perform uncommon and difficult, but necessary clinical studies to evaluate novel vaccines and therapeutics particularly universal influenza vaccines in the human challenge model and extremely novel universal vaccines for vector borne disease like Dengue, Zika, and Leishmaniasis.
Tour the Special Clinical Studies Unit
What is it Like to Participate?
To me, science is better than magic. Through scientific research, we gain the ability to prevent or cure disease.
– Sara Jones
Read more about participating in the Participant's Guide to Clinical Trials
Read some Participant Testimonials to see more about what its like to participate.
You can also watch a series of short informational videos from Health and Human Services about participating in clinical trials.
Contact Information
For questions about participating in clinical studies, contact:
Office of Patient Recruitment
Toll Free: 1-800-411-1222
TTY: 1-866-411-1010
Se habla español. Email: prpl@mail.cc.nih.gov